S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
New CBOE “special perk” helps traders target income every weekend (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
New CBOE “special perk” helps traders target income every weekend (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
New CBOE “special perk” helps traders target income every weekend (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
New CBOE “special perk” helps traders target income every weekend (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
New CBOE “special perk” helps traders target income every weekend (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
New CBOE “special perk” helps traders target income every weekend (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
New CBOE “special perk” helps traders target income every weekend (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
New CBOE “special perk” helps traders target income every weekend (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war

EV Biologics Stock Price, News & Analysis (OTCMKTS:YECO)

$1.10
-0.02 (-1.79%)
(As of 12/1/2023 ET)
Compare
Today's Range
$1.10
$1.10
50-Day Range
$0.70
$1.66
52-Week Range
$0.70
$2.34
Volume
1,000 shs
Average Volume
92 shs
Market Capitalization
$11.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

YECO stock logo

About EV Biologics Stock (OTCMKTS:YECO)

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.

YECO Stock Price History

YECO Stock News Headlines

New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
EV Biologics Updates on Funding and Sales
How the New EV Tax Credit Will Affect Your Auto Loan
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
EV Biologics Hires Senior Chief Financial Officer
EV Biologics, Inc. (YECO)
Best EV Penny Stocks
EV Biologics Generates Mesenchymal Stem Cell Lines
EV Biologics Updates on Excyte Subsidiary Funding
EV Biologics Initiates PCAOB Audit to Seek Uplift to OTCQX
See More Headlines
Receive YECO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EV Biologics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/03/2023
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Concrete, gypsum, & plaster products
Sub-Industry
N/A
Current Symbol
OTCMKTS:YECO
Fax
N/A
Employees
284
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
6,006,000
Market Cap
$11.25 million
Optionable
Not Optionable
Beta
0.06
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Daniel S. McKinney (Age 61)
    Founder, Chairman & CEO
  • Mr. Monte Fisher
    Chief Financial Officer
  • Mr. William Bossung
    Corporate Finance Director & Corporate Secretary














YECO Stock Analysis - Frequently Asked Questions

How have YECO shares performed in 2023?

EV Biologics' stock was trading at $1.70 at the start of the year. Since then, YECO shares have decreased by 35.3% and is now trading at $1.10.
View the best growth stocks for 2023 here
.

Are investors shorting EV Biologics?

EV Biologics saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 1,900 shares, a decline of 17.4% from the October 31st total of 2,300 shares. Based on an average daily volume of 300 shares, the short-interest ratio is presently 6.3 days.
View EV Biologics' Short Interest
.

How do I buy shares of EV Biologics?

Shares of YECO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:YECO) was last updated on 12/3/2023 by MarketBeat.com Staff

My Account -